Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review Jan K. KalinskiBo XuMilind Y. Desai Review Article Open access 19 July 2024
Sodium-Glucose Cotransporter-2 Inhibitors: Elevating Standards in Cardiovascular Secondary Prevention Antonio Greco Commentary 17 July 2024
The Use of Drugs that Should be Avoided or Used with Caution in Patients Hospitalized for Acute Decompensated Heart Failure Marwan Sheikh-Taha Original Research Article 08 July 2024
Empagliflozin Effects in Patients with ST-Elevation Myocardial Infarction Undergoing Primary PCI: The EMI-STEMI Randomized Clinical Trial Elnaz KhaniNaser AslanabadiTaher Entezari-Maleki Original Research Article 05 July 2024
Impact of SGLT2 Inhibitors on Atrial Fibrillation Recurrence after Catheter Ablation in Type 2 Diabetes Mellitus: A Meta-Analysis of Reconstructed Kaplan–Meier Curves with Trial Sequential Analysis Youssef SolimanMohamed AbuelazmHatem Hassaballa Systematic Review Open access 04 July 2024
Effect of Activated Charcoal on Mavacamten Pharmacokinetics in Healthy Participants Samira MeraliManting ChiangVidya Perera Original Research Article Open access 26 June 2024 Pages: 569 - 575
The Efficacy of Tafolecimab in Chinese Patients with Hypercholesterolemia: A Systematic Review and Meta-analysis Eeshal FatimaZaheer QureshiFaryal Altaf Systematic Review 24 June 2024
Strategy for an early simultaneous introduction of four-pillars of heart failure therapy: results from a single center experience Paolo SeverinoAndrea D’AmatoCarmine Dario Vizza Original Research Article Open access 23 June 2024
Ongoing and Future Clinical Trials of Pharmacotherapy for Heart Failure Taha MansoorSubaina N. KhalidAbdul Mannan Khan Minhas Review Article 22 June 2024 Pages: 481 - 504
Impact of Prolonged Dual Antiplatelet Therapy After Bifurcation Percutaneous Coronary Intervention in Patients with High Ischemic Risk Dmitrii KhelimskiiIvan BessonovOleg Krestyaninov Original Research Article 13 June 2024 Pages: 577 - 588
Towards the Fifth Pillar for the Treatment of Heart Failure with Reduced Ejection Fraction: Vericiguat in Older and Complex Patients Luigi SpadaforaMarco BernardiErica Rocco Review Article Open access 10 June 2024 Pages: 469 - 479
Efficacy and Safety of Alprostadil in Microcirculatory Disturbances During Emergency PCI: A Meta-Analysis of Randomized Controlled Trials Yue ChenMengdi WangMin Zeng Systematic Review 08 June 2024 Pages: 547 - 556
Correction: The Rationale for Using Fixed‑Dose Combination Therapy in the Management of Hypertension in Colombia: A Narrative Review Dora Inés Molina de SalazarAntonio CocaDaniel Piskorz Correction Open access 30 May 2024 Pages: 589 - 589
Efficacy and Safety of Interleukin-1 Inhibitors in the Management of Patients with Recurrent Pericarditis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Yong WanShuai HePengcheng Gan Systematic Review 29 May 2024 Pages: 537 - 545
Benefits and Risks of Antihyperlipidemic Medication in Adults with Different Low-Density Lipoprotein Cholesterol Based on the Number Needed to Treat Hong-Fei WangYu-Cheng MaoQing-Bao Tian Original Research Article 23 May 2024 Pages: 557 - 568
Beyond Weight Loss: Evaluating Cardiovascular Advantages of GLP-1 Receptor Agonists Teresa VezzaVíctor M. Víctor Commentary 15 May 2024 Pages: 505 - 507
Cardiovascular Benefits of GLP-1 Receptor Agonists in Patients Living with Obesity or Overweight: A Meta-analysis of Randomized Controlled Trials Gustavo de Oliveira AlmeidaThiago Faraco NienkötterCamila Mota Guida Systematic Review 11 May 2024 Pages: 509 - 521
Evaluating the Effectiveness and Safety of Evinacumab in Treating Hypercholesterolemia and Hypertriglyceridemia: A Systematic Review and Meta-analysis of Randomized Controlled Trials Hussain Sohail RangwalaHareer FatimaMuhammad Saqlain Mustafa Systematic Review 07 May 2024 Pages: 523 - 535
Comparative Genitourinary Safety of In-class Sodium-Glucose Cotransporter-2 Inhibitors among Patients with Heart Failure with Preserved Ejection Fraction: A Cohort Study Munaza RiazJingchuan GuoHaesuk Park Original Research Article 30 April 2024 Pages: 455 - 464
Differential Use of Glycoprotein IIb/IIIa Inhibitors with Bivalirudin in Patients with STEMI Undergoing PCI: A Systematic Review and Meta-Analysis Hasan MushahidSyeda Ayesha ShahMuhammad Shariq Usman Systematic Review 29 April 2024 Pages: 385 - 398
Cost–Utility Analysis of Vericiguat in Heart Failure with Reduced Ejection Fraction After Worsening Heart Failure Events in China Penglei ChenYixiang WangXuwei Zheng Original Research Article 15 April 2024 Pages: 445 - 454
Evaluation of the Lifetime Benefits of Metformin and SGLT2 Inhibitors in Type 2 Diabetes Mellitus Patients with Cardiovascular Disease: A Systematic Review and Two-Stage Meta-Analysis Hon Jen WongNorman H. LinChing-Hui Sia Systematic Review 08 April 2024 Pages: 371 - 383
Trends in Oral Anticoagulant Use and Individual Expenditures Across the United States from 2014 to 2020 Omar S. AlkheziLeo F. BuckleyJohn Fanikos Original Research Article 07 April 2024 Pages: 433 - 444
Comparative Safety and Efficacy of Low/Moderate-Intensity Statin plus Ezetimibe Combination Therapy vs. High-Intensity Statin Monotherapy in Patients with Atherosclerotic Cardiovascular Disease: An Updated Meta-Analysis Ishaque HameedSyeda Ayesha ShahMohammad Hamza Original Research Article 05 April 2024 Pages: 419 - 431
Authors’ Reply to Rangwala et al: “Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis” Ioannis BellosSmaragdi MarinakiVassiliki Benetou Letter to the Editor 04 April 2024 Pages: 467 - 468
Treatment Patterns, Outcomes, and Persistence to Newly Started Heart Failure Medications in Patients with Worsening Heart Failure: A Cohort Study from the United States and Germany Alexander MichelCoralie LecomteThomas Evers Original Research Article 04 April 2024 Pages: 409 - 418
Digoxin is Not Related to Mortality in Patients with Heart Failure: Results from the SELFIE-TR Registry Rengin Çetin GüvençTolga Sinan GüvençMehmet Birhan Yılmaz Original Research Article 04 April 2024 Pages: 399 - 408
Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review Hiroaki HiraiwaTakahiro OkumuraToyoaki Murohara Review Article Open access 04 April 2024 Pages: 343 - 369
Advancing Guideline-Directed Medical Therapy in Heart Failure: Overcoming Challenges and Maximizing Benefits Zixi ZhangCancan WangQiming Liu Review Article Open access 03 April 2024 Pages: 329 - 342
Comment on: “Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis” Hussain Sohail RangwalaHareer FatimaBurhanuddin Sohail Rangwala Letter to the Editor 02 April 2024 Pages: 465 - 466
Efficacy of Intravenous Iron in Patients with Heart Failure with Reduced Ejection Fraction and Iron Deficiency: A Systematic Review and Meta-Analysis of Randomized Control Trials Andrew SephienDenisse Camille DaytoAmbuj Kumar Systematic Review 22 March 2024 Pages: 285 - 302
The Rationale for Using Fixed-Dose Combination Therapy in the Management of Hypertension in Colombia: A Narrative Review Dora Inés Molina de SalazarAntonio CocaDaniel Piskorz Review Article Open access 15 March 2024 Pages: 197 - 209
New Perspectives on the Role and Therapeutic Potential of Melatonin in Cardiovascular Diseases Pengchen GuYuxin WuWeiwei Lu Review Article 04 March 2024 Pages: 171 - 195
Acetazolamide as an Adjunctive Diuretic Therapy for Patients with Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis Ahmed Kamal SiddiqiMuhammad Talha ManiyaMuhammad Shahzeb Khan Systematic Review 28 February 2024 Pages: 273 - 284
Eligibility and Cost-Utility Analysis of Dapagliflozin in Patients with Heart Failure Across the Whole Spectrum of Ejection Fraction in South Korea Eui-Soon KimSun-Kyeong ParkSang Hong Baek Original Research Article 27 February 2024 Pages: 313 - 324
Comparative Effectiveness and Safety of Direct Oral Anticoagulants Compared with Warfarin in Patients with Low Bodyweight who have Atrial Fibrillation: A Systematic Review and Meta-analysis Mohamed Nabil ElshafeiAhmed El-BardissyMohammed Danjuma Systematic Review Open access 22 February 2024 Pages: 255 - 271
Management of Hypertension in the Asia-Pacific Region: A Structured Review Abdul R. A. RahmanJose Donato A. MagnoRohit Khurana Review Article Open access 08 February 2024 Pages: 141 - 170
Serum Cystatin C as a Risk Factor for Supratherapeutic Digoxin Concentration in Elderly Patients with Heart Failure and Chronic Kidney Disease Jie-Jiu LuTao-Tao Liu Original Research Article 01 February 2024 Pages: 303 - 311
Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis Ioannis BellosSmaragdi MarinakiVassiliki Benetou Systematic Review Open access 01 February 2024 Pages: 241 - 253
Author’s Reply to Kow et al.: “Comparison of Clinical Outcomes between Ticagrelor and Clopidogrel in East-Asian Patients with Acute Coronary Syndrome: Large Cohort Study” Hsiu-Yu FangWei-Chieh Lee Letter to the Editor 25 January 2024 Pages: 327 - 328
Comment on: “Comparison of Clinical Outcomes Between Ticagrelor and Clopidogrel in East-Asian Patients with Acute Coronary Syndrome: Large Cohort Study” Chia Siang KowAbdullah Faiz ZaihanSyed Shahzad Hasan Letter to the Editor 25 January 2024 Pages: 325 - 326
SAMe-TT2R2 Score to Predict Time in Therapeutic Range of Vitamin K Antagonists in Asian and Non-Asian patients: A Systematic Review and Meta-analysis Natnicha PoonchuaySurasak SaokaewSupatcha Incomenoy Systematic Review 22 January 2024 Pages: 211 - 240
Safety and Efficacy of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors After Acute Coronary Syndrome: A Meta-analysis of Randomized Controlled Trials Ahmed AtiaHeba AboeldahabAhmed Abdelaziz Systematic Review Open access 19 January 2024 Pages: 83 - 102
Iron Dyshomeostasis and Mitochondrial Function in the Failing Heart: A Review of the Literature Seyed Ali Mousavi-AghdasEbrahim FarashiNasim Naderi Review Article 29 December 2023 Pages: 19 - 37
SGLT2 Inhibitors for Heart Failure with Preserved Ejection Fraction: What Hospitalists Need to Know Stephen J. GreeneGregg C. FonarowJaved Butler Commentary 29 December 2023 Pages: 1 - 4
The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective Andre LamyJohn Eikelboomthe COMPASS Investigators Original Research Article Open access 28 December 2023 Pages: 117 - 127
Rivaroxaban Plasma Concentration and Clinical Outcomes on Older Patients with Non-valvular Atrial Fibrillation and Pulmonary Infection Yan YuHaobin LiGuangchun Sun Original Research Article 24 December 2023 Pages: 129 - 139
Safety and Efficacy of Cangrelor in Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis Mostafa Reda MostafaMohamed Magdi EidAndrew M. Goldsweig Systematic Review 23 November 2023 Pages: 71 - 81
The Use of Sodium-Glucose Cotransporter-2 Inhibitors in Coronary Revascularization: Where Are We Now? A Systematic Review Ryaan EL-AndariNicholas M. FialkaJeevan Nagendran Systematic Review 17 November 2023 Pages: 55 - 69
A Systematic Review of Novel Therapies of Pulmonary Arterial Hypertension Omnia Azmy NabehAlaa I. SaudSoha Aly Elmorsy Systematic Review Open access 09 November 2023 Pages: 39 - 54
